BRPI0602106A - Process for the preparation of a product of Passiflora incarnata l., pharmaceutical, pharmaceutical composition, uses and method of treating anxiety and insomnia - Google Patents

Process for the preparation of a product of Passiflora incarnata l., pharmaceutical, pharmaceutical composition, uses and method of treating anxiety and insomnia

Info

Publication number
BRPI0602106A
BRPI0602106A BRPI0602106-9A BRPI0602106A BRPI0602106A BR PI0602106 A BRPI0602106 A BR PI0602106A BR PI0602106 A BRPI0602106 A BR PI0602106A BR PI0602106 A BRPI0602106 A BR PI0602106A
Authority
BR
Brazil
Prior art keywords
pharmaceutical
product
insomnia
preparation
pharmaceutical composition
Prior art date
Application number
BRPI0602106-9A
Other languages
Portuguese (pt)
Inventor
Luiz Francisco Pianowski
Original Assignee
Ache Lab Farmaceuticos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ache Lab Farmaceuticos Sa filed Critical Ache Lab Farmaceuticos Sa
Priority to BRPI0602106A priority Critical patent/BRPI0602106B8/en
Priority to PCT/BR2007/000127 priority patent/WO2007137380A1/en
Publication of BRPI0602106A publication Critical patent/BRPI0602106A/en
Publication of BRPI0602106B1 publication Critical patent/BRPI0602106B1/en
Publication of BRPI0602106B8 publication Critical patent/BRPI0602106B8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROCESSO PARA PREPARAçãO DE UM PRODUTO à BASE DE PASSIFLORA INCARNATA L., PRODUTO FARMACêUTICO, COMPOSIçãO FARMACêUTICA, USOS E MéTODO DE TRATAMENTO DE ANSIEDADE E INSÈNIA A presente invenção refere-se, de forma geral, a um produto farmacêutico em pó à base de Passiflora incarnata L., substancialmente desprovido de alcalóides, que proporciona maior segurança ao paciente, com manutenção da ação farmacológica sobre ansiedade e insónia.PROCESS FOR PREPARATION OF A PASSIFLORA INCARNATA L. PRODUCT, PHARMACEUTICAL PRODUCT, PHARMACEUTICAL COMPOSITION, USES AND METHOD OF TREATING ANXIETY This invention relates generally to a Passifora powder based pharmaceutical product. incarnata L., substantially devoid of alkaloids, which provides greater patient safety, while maintaining pharmacological action on anxiety and insomnia.

BRPI0602106A 2006-05-25 2006-05-25 process for preparing a product based on passionflower incarnata l. BRPI0602106B8 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0602106A BRPI0602106B8 (en) 2006-05-25 2006-05-25 process for preparing a product based on passionflower incarnata l.
PCT/BR2007/000127 WO2007137380A1 (en) 2006-05-25 2007-05-24 Pharmaceutical product based on passiflora incarnata l., uses therefor and method to treat anxiety and insomnia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0602106A BRPI0602106B8 (en) 2006-05-25 2006-05-25 process for preparing a product based on passionflower incarnata l.

Publications (3)

Publication Number Publication Date
BRPI0602106A true BRPI0602106A (en) 2008-01-15
BRPI0602106B1 BRPI0602106B1 (en) 2018-04-17
BRPI0602106B8 BRPI0602106B8 (en) 2021-05-25

Family

ID=38778034

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0602106A BRPI0602106B8 (en) 2006-05-25 2006-05-25 process for preparing a product based on passionflower incarnata l.

Country Status (2)

Country Link
BR (1) BRPI0602106B8 (en)
WO (1) WO2007137380A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0801239A2 (en) * 2008-04-01 2009-11-17 Ache Lab Farmaceuticos Sa use of one or more benzopyranones, pharmaceutical composition and method for the prevention or treatment of monoamine oxidase-associated diseases, disorders and disorders
KR20150019505A (en) * 2013-08-14 2015-02-25 대화제약 주식회사 Pharmaceutical Compositions comprising flavone-6-C-glucose derivatives for treating or preventing neuropsychiatric disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE212790T1 (en) * 1995-03-06 2002-02-15 Flachsmann Ag Emil METHOD FOR REMOVAL OF UNDESIRABLE LIPOPHILIC CONTAMINANTS AND/OR RESIDUE CONTAINED IN BEVERAGES OR VEGETABLE PREPARATIONS
CH693403A5 (en) * 1998-09-17 2003-07-31 Flachsmann Ag Emil A process for the removal of undesired toxic alkaloids from plants or from plant preparations.
ES2274163T3 (en) * 2003-12-04 2007-05-16 Cognis Ip Management Gmbh PREPARATION FOR APPLICATION (I) ORAL AND / OR TOPICS.

Also Published As

Publication number Publication date
WO2007137380A1 (en) 2007-12-06
BRPI0602106B1 (en) 2018-04-17
BRPI0602106B8 (en) 2021-05-25

Similar Documents

Publication Publication Date Title
BRPI0714539B8 (en) process for obtaining opioid extended release pharmaceutical dosage form
BR112012009376B8 (en) solid pharmaceutical composition comprising a sglt-2 inhibitor and its pharmaceutical dosage form
BRPI0908421C1 (en) stable solution of a pharmaceutical compound
CL2012000185A1 (en) Oxazine or oxazepine derived compounds, bace inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; and its use for the treatment of cognitive impairment, amyloid neuropathy, or Alzheimer's disease.
CO6551721A2 (en) NEW KINASE MODULATORS
CL2008003316A1 (en) Crystal form vi of agomelatine; preparation procedures; Pharmaceutical composition, useful for the treatment of stress, anxiety, major depression, panic attacks, Parkinson's disease, epilepsy, Alzheimer's disease.
BR112015000150A2 (en) controlled release abuse deterrent pharmaceutical compositions
BR112012010706A2 (en) compound, pharmaceutical composition, pharmaceutical combination, use of a compound, and methods for treating a disease or condition, and for inhibiting bromodomain
BR112013022789A2 (en) pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
NI200800207A (en) CYTOTOXIC AGENTS INCLUDING NEW DERIVATIVES OF TOMAIMYCIN
ECSP10010289A (en) DOSAGE REGIME ASSOCIATED WITH INJECTABLE PALIPERIDONE ESTERS OF PROLONGED ACTION
CO6501190A2 (en) PCSK9 VACCINE
CL2007002121A1 (en) COMPOUNDS DERIVED FROM PIRAZOLES, GLUCOQUINASA ACTIVATORS; PREPARATION PROCESS OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND USE FOR THE TREATMENT OF DISEASES AND / OR METABOLIC DISORDERS, AS DIAB
CL2013000063A1 (en) A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
BRPI0911273B8 (en) pharmaceutical composition comprising a dpp-iv inhibitor, as well as a process for its preparation
BRPI0609393B8 (en) uses of an 11-deoxy-prostaglandin compound
UY31314A1 (en) HETEROCICLIC AMIDAS AND ITS METHODS OF USE-976
CR20120008A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
BR112015021856A2 (en) processes and intermediates for the preparation of a medicament
UY30986A1 (en) FLUORINATED DEFERIPRONE DERIVATIVES
UY31322A1 (en) HETEROCYCLIC AMIDAS AND ITS METHODS OF USE-975
CO6382089A2 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES CAUSED BY A B-AMYLOID AND SINUCLEINOPATIAS
CL2008000738A1 (en) COMPOUNDS DERIVED FROM MALONAMIDE; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF DEPRESSION, PARKINSON AND ALZHEIMER'S DISEASE, BETWEEN OTHER DISEASES
BR112012015202A2 (en) "Iota - and / or kappa-carrageenate together with a neuraminidase inhibitor, method for the prophylactic or therapeutic treatment of a symptom, condition or disease, pharmaceutical composition, and kit of parts."
BRPI0818813A2 (en) Methylbenzimidazole-derived compounds, process for the manufacture of such compounds, pharmaceutical compositions comprising them, method for the therapeutic and / or prophylactic treatment of diseases that are affected by fxr modulators and use of such compounds

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07C 227/28 , A61K 8/97

Ipc: A61K 36/185 (2006.01), A61P 25/22 (2006.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/05/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: "INPI NO 52402.002941/2022-72 ORIGEM: 14A VARA CIVEL FEDERAL DE SAO PAULO (TRF3) PROCESSO NO: NUP 01032.300031/2022-77 SUBJUDICE COM PEDIDO DE ANTECIPACAO DE TUTELA AUTOR: LUIZ FRANCISCO PIANOWSKI REU(S): ACHE LABOTATORIOS FARMACEUTICOS S/A E INSTITUTONACIONAL DA PROPRIEDADE INTELECTUAL"